News
RVVTF
0.021
-12.35%
-0.003
Weekly Report: what happened at RVVTF last week (0601-0605)?
Weekly Report · 1d ago
Weekly Report: what happened at RVVTF last week (0525-0529)?
Weekly Report · 06/01 09:59
Weekly Report: what happened at RVVTF last week (0518-0522)?
Weekly Report · 05/25 10:01
Revive expands bucillamine program across infectious diseases
TipRanks · 05/20 11:57
Weekly Report: what happened at RVVTF last week (0511-0515)?
Weekly Report · 05/18 10:01
Weekly Report: what happened at RVVTF last week (0504-0508)?
Weekly Report · 05/11 09:59
Weekly Report: what happened at RVVTF last week (0427-0501)?
Weekly Report · 05/04 09:58
Weekly Report: what happened at RVVTF last week (0420-0424)?
Weekly Report · 04/27 09:59
Weekly Report: what happened at RVVTF last week (0413-0417)?
Weekly Report · 04/20 09:56
Weekly Report: what happened at RVVTF last week (0406-0410)?
Weekly Report · 04/13 09:59
Weekly Report: what happened at RVVTF last week (0330-0403)?
Weekly Report · 04/06 09:59
Weekly Report: what happened at RVVTF last week (0323-0327)?
Weekly Report · 03/30 10:00
Weekly Report: what happened at RVVTF last week (0316-0320)?
Weekly Report · 03/23 09:56
Weekly Report: what happened at RVVTF last week (0309-0313)?
Weekly Report · 03/16 09:56
Revive Extends Bucillamine Patent Shield Across Nerve-Agent and Infectious Disease Uses
TipRanks · 03/11 12:13
Revive Therapeutics announces North American patent filings for bucillamine
TipRanks · 03/11 11:40
Weekly Report: what happened at RVVTF last week (0302-0306)?
Weekly Report · 03/09 09:57
Weekly Report: what happened at RVVTF last week (0223-0227)?
Weekly Report · 03/02 09:56
Weekly Report: what happened at RVVTF last week (0216-0220)?
Weekly Report · 02/23 09:56
Weekly Report: what happened at RVVTF last week (0209-0213)?
Weekly Report · 02/16 09:56
More
Webull provides a variety of real-time RVVTF stock news. You can receive the latest news about Revive Therapeutics Ltd through multiple platforms. This information may help you make smarter investment decisions.
About RVVTF
Revive Therapeutics Ltd. is a Canada-based life sciences company. The Company is focused on the research and development of therapeutics for infectious diseases and medical countermeasures. It is engaged in exploring the use of Bucillamine for the potential treatment of nerve agent exposure and long COVID. The Company, through its diagnostics division, is evaluating a point-of-care in vitro diagnostic device that aids in the detection of post COVID-19 conditions or Long COVID. The Company is also advancing the development of Psilocybin and molecular hydrogen therapeutics through various programs. The Company's subsidiaries include Revive Therapeutics Inc. (Ontario), Revive Diagnostics Inc., and Psilocin Pharma Corp. (Ontario).